Almirall Jordi, Boixeda Ramon, Bolíbar Ignasi, Bassa Josep, Sauca Goretti, Vidal Josep, Serra-Prat Mateu, Balanzó Xavier
Critical Care Unit, Hospital de Mataró, Universitat Autònoma de Barcelona, Mataró, Barcelona, Spain.
Respir Med. 2007 Oct;101(10):2168-75. doi: 10.1016/j.rmed.2007.05.007. Epub 2007 Jul 12.
A few population-based studies assessing the etiology of community-acquired pneumonia in both hospitalized and ambulatory patients, with special emphasis on the etiologic role of viral infections, have been reported. The purpose of this study was to assess microbiological differences according to initial site of care in patients with community-acquired pneumonia.
We studied 496 patients > 14 years of age collected from the study samples of three population-based studies carried out in the same geographical area ("Maresme" region in the Mediterranean coast in Barcelona, Spain) with the same methodology over an 8-year period (1987-1995).
Fifty-six percent of patients were hospitalized and 44% were treated at home. Of the 474 patients with etiological evaluation, 195 patients had an identifiable etiology (overall diagnostic yield 41%). Streptococcus pneumoniae was the most common causative organism. Viral infection was diagnosed in 26.5% of hospitalized patients vs. 13.2% of ambulatory patients (P=0.03). Twenty-five percent of the 68 patients with documented etiology treated at home had Chlamydia pneumoniae infection compared with 14.3% of those treated in the hospital. Ten percent of hospitalized patients had pneumonia caused by two pathogens compared with 9.7% of ambulatory patients. The association of viruses and bacteria was the most frequent cause of dual infection (79% inpatients, 67% outpatients).
This study has provided information on etiology of community-acquired pneumonia in hospitalized patients and in patients treated at home. A considerable proportion of patients had viral pneumonia, frequently requiring hospital admission for inpatient care.
已有一些基于人群的研究评估了住院和门诊患者社区获得性肺炎的病因,特别强调了病毒感染的病因学作用。本研究的目的是评估社区获得性肺炎患者根据初始治疗地点的微生物学差异。
我们研究了496例年龄大于14岁的患者,这些患者来自于在同一地理区域(西班牙巴塞罗那地中海沿岸的“马雷斯梅”地区)进行的三项基于人群的研究的样本,采用相同的方法,历时8年(1987 - 1995年)。
56%的患者住院治疗,44%的患者在家治疗。在474例进行病因评估的患者中,195例患者有可明确的病因(总体诊断率为41%)。肺炎链球菌是最常见的致病微生物。病毒感染在26.5%的住院患者中被诊断出,而在门诊患者中为13.2%(P = 0.03)。在家接受治疗的68例有明确病因的患者中,25%患有肺炎衣原体感染,而在医院接受治疗的患者中这一比例为14.3%。10%的住院患者肺炎由两种病原体引起,而门诊患者中这一比例为9.7%。病毒与细菌的联合感染是最常见的双重感染原因(住院患者中为79%,门诊患者中为67%)。
本研究提供了关于住院患者和在家治疗患者社区获得性肺炎病因的信息。相当一部分患者患有病毒性肺炎,常常需要住院接受治疗。